IBM and Agilent are bringing two technologies together to create an informatics system designed to help researchers collaborate through the entire discovery process so they can design better drugs and get them to market faster. The two technologies are IBM’s DiscoveryLink data integration software and Agilent’s new Synapsia Informatics Workbench software.